Journal Highlight: Identification In Silico and In Vitro of Novel Trypanosomicidal Drug-Like Compounds

Identification In Silico and In Vitro of Novel Trypanosomicidal Drug-Like Compounds

Chemical Biology & Drug Design, 2012, 80, 38-45
Juan A. Castillo-Garit, Oremia del Toro-Cortes, Vladimir V. Kouznetsov, Cristian Ochoa Puentes, Arnold R. Romero Bohorquez, Maria C. Vega, Miriam Rolon, Jose A. Escario, Alicia Gomez-Barrio, Yovani Marrero-Ponce, Francisco Torrens, Concepcion Abad

Abstract: Atom-based bilinear indices and linear discriminant analysis are used to discover novel trypanosomicidal compounds. The obtained linear discriminant analysis-based quantitative structure–activity relationship models, using non-stochastic and stochastic indices, provide accuracies of 89.02% (85.11%) and 89.60% (88.30%) of the chemicals in the training (test) sets, respectively. Later, both models were applied to the virtual screening of 18 in-house synthesized compounds to find new pro-lead antitrypanosomal agents. The in vitro antitrypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi is assayed. Predictions agree with experimental results to a great extent (16/18) of the chemicals. Sixteen compounds show more than 70% of epimastigote inhibition at a concentration 100 μg/mL. In addition, three compounds (CRIS 112, CRIS 140 and CRIS 147) present more than 70% of epimastigote inhibition at a concentration of 10 μg/mL (79.95%, 73.97% and 78.13%, respectively) with low values of cytotoxicity (19.7%, 7.44% and 20.63%, correspondingly).Taking into account all these results, we could say that these three compounds could be optimized in forthcoming works. Even though none of them resulted more active than nifurtimox, the current results constitute a step forward in the search for efficient ways to discover new lead antitrypanosomals.

• This paper is free to view for all users registered on separationsNOW.com until the end of September 2012.
  After this time, you can purchase it using Pay-Per-View on Wiley Online Library.

• Click here to access the abstract of this paper >>>
  From the abstract page you can progress to read the full paper.

• Click here for more information about Chemical Biology & Drug Design >>>